Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06489301 · ClinicalTrials.gov registry record · NA
Mechanisms for Laser-Induced Rejuvenation
A NA study, sponsored by Wright State University.
- Recruiting
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT06489301: Recruiting NA study, sponsored by Wright State University.
NCT06489301 is a NA study that is actively recruiting participants, run by Wright State University. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06489301, a NA study, is actively recruiting participants, sponsored by Wright State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
It has shown that laser wounding of geriatric skin protects it against skin cancer. The purpose of this study is to determine the origin of cells called fibroblasts which are present after treatment with Fractionated Laser Resurfacing (FLR). These cells restore a youth-like ultraviolet B (UVB) response, but where they come from is currently unknown. The study recruits subjects who are scheduled to undergo abdominoplasties to investigate the origin of those cells stimulated by laser treatment.
Primary Outcome
Identify cells in the skin that have been wounded by FLR at 2 weeks and 1 week previously, for cells that co-express markers for both fibroblasts and monocytes by using single cell RNA-sequencing
Interventions
- DEVICE Fractionated Laser Resurfacing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2025-07-16 |
| Est. Completion | 2028-12 |
| Phase | NA |
What NCT06489301 shows while recruiting
NCT06489301 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Fractionated Laser Resurfacing is the first listed.
NCT06489301 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06489301 about?
NCT06489301 is a clinical study titled "Mechanisms for Laser-Induced Rejuvenation". It has shown that laser wounding of geriatric skin protects it against skin cancer. The purpose of this study is to determine the origin of cells called fibroblasts which are present after treatment with Fractionated Laser Resurfacing (FLR). These cells restore a youth-like ultraviolet B (UVB) respo...
What is the current status of trial NCT06489301?
This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2025-07-16. Estimated completion is 2028-12.
What interventions are being tested in trial NCT06489301?
The interventions under investigation include: Fractionated Laser Resurfacing (DEVICE).
Who is sponsoring clinical trial NCT06489301?
This trial is sponsored by Wright State University, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06489301's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI